Company: AstraZeneca
Location: Cambridge
Posted: May 11th, 2026
The Discovery Centre, Cambridge Biomedical Campus, Cambridge, UK
£40,000 gross (subject to deductions in line with UK policy) plus benefit fund and bonus.
A doctoral position is available for 3 years to work with AstraZeneca (Pharmaceutical Sciences, Early Chemical Development, Biocatalysis Team) and Professor Florian Hollfelder at the Biochemistry Department of Cambridge University (https://hollfelder.bioc.cam.ac.uk/). The project is part of the Horizon Europe Eu Marie Curie Network MetaExplore (www.metaexplore.eu/) and involves collaborations with various EU and UK groups on harnessing environmental sources for novel biocatalysts that may play a role in future sustainable processes with higher resource and energy efficiency.
A major barrier to the wider application of biocatalysis in Pharma is the time required to optimise poor enzyme scaffolds into industrially viable biocatalysts via directed evolution. Even with state‑of‑the‑art platforms for library production, screening, and evaluation, timelines for an evolution cycle remain non‑compatible with the often-accelerated timelines of compound manufacturing campaigns.
This mismatch underscores the need for a new framework that avoids inefficient exploration of the protein fitness landscape, enabling protein engineers to navigate faster trajectories toward high‑fitness solutions across sequence space. The goal is not necessarily to shorten each evolutionary round, but to improve hit quality, increase success rates, and minimise evolutionary dead ends.
Timings of these secondments are to be confirmed.
Leverage microfluidics and next‑generation sequencing to generate expansive, high‑resolution datasets suitable for machine learning‑guided directed evolution. This approach will accelerate navigation of high‑dimensional sequence space while reducing design‑build‑test iterations required to deliver industrially viable biocatalysts.
For more information about MetaExplore, please visit: https://metaexplore.eu/
30-Apr-2026
14-May-2026
We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best.
#J-18808-Ljbffr